Metal catalysis has become a central enabling technology in modern small molecule development, giving drug discovery and process teams practical access to efficient C-C bond formation, selective reductions, carbonylation, borylation, and asymmetric synthesis pathways that would otherwise be difficult to execute with speed and control. For pharmaceutical and biotech programs, the real value of metal catalysis lies not only in reaction feasibility, but in how efficiently a catalytic step can be optimized, scaled, purified, and integrated into a robust manufacturing route. BOC Sciences provides comprehensive metal catalysis technology services spanning catalyst and ligand screening, route design, reaction condition optimization, impurity control, and scalable process implementation for complex intermediates, APIs, and structurally diverse small molecules. Our team helps clients solve practical development problems such as low conversion, poor chemoselectivity, catalyst poisoning, heterogeneous slurry handling, trace metal burden, and reproducibility during scale-up, enabling catalytic processes that are scientifically strong and operationally dependable.
We establish efficient screening workflows to identify the right metal source, ligand set, base, solvent, and additive package for difficult transformations, accelerating route selection and reducing empirical trial-and-error in early development.
Our team develops robust coupling reaction strategies for pharmaceutically relevant scaffolds, including aryl-aryl, aryl-heteroaryl, aryl-amine, and alkynyl transformations used in fragment elaboration, lead optimization, and API route design.
We support selective hydrogenation, transfer hydrogenation, reductive amination, and asymmetric catalytic transformations, combining catalytic performance with process practicality for stereochemically demanding pharmaceutical targets.
We integrate catalytic reaction design with downstream purification planning to reduce trace metal burden, simplify processing, and improve route consistency for advanced intermediates and APIs.
BOC Sciences helps transform catalytic concepts into reproducible, scalable synthetic solutions for discovery, process R&D, and API manufacturing programs.
We use compact parallel screening strategies to rapidly compare catalyst precursors, ligands, solvents, bases, and additive combinations, enabling fast identification of productive catalytic windows for challenging pharmaceutical substrates.
Real-time and staged analytical monitoring supports mechanistic understanding, endpoint definition, impurity tracking, and catalyst deactivation studies, allowing informed optimization rather than purely empirical iteration.
We apply statistically guided optimization to map the interaction of temperature, catalyst loading, ligand ratio, solvent composition, pressure, and reagent concentration, defining robust operating spaces for catalytic processes.
Our development strategies address slurry rheology, catalyst wetting, filtration behavior, mass transfer limitations, and solid carryover to improve reproducibility for hydrogenation and supported-metal systems.
We combine reaction engineering with purification design to minimize metal carryover, reduce reprocessing needs, and support efficient downstream isolation of catalytic products and intermediates.
From gram-scale proof of concept to kilo-scale implementation, we translate catalytic conditions into practical manufacturing workflows with attention to mixing, dosing sequence, heat release, gas handling, and isolation efficiency.
Our metal catalysis technology services support a wide range of drug discovery and process chemistry applications. We work with early screening campaigns, lead series expansion, advanced intermediates, and late-stage synthetic route refinement for structurally diverse small molecules.
Share your target transformation, current route, or reaction bottleneck. Our chemists will design a practical catalytic development strategy focused on selectivity, throughput, cleanup, and scale-up readiness.
We evaluate substrate structure, functional group compatibility, target bond disconnection, likely catalyst families, and known failure modes to define a realistic catalytic development path aligned with your project stage.
We perform focused catalyst, ligand, base, solvent, temperature, and concentration screening to identify productive conditions, then refine the process for conversion, selectivity, isolation behavior, and operational simplicity.
Once an effective catalytic step is defined, we integrate it into the broader synthetic sequence, assessing reagent order, workup design, catalyst recovery opportunities, and compatibility with upstream and downstream unit operations.
We transfer optimized catalytic chemistry into a scalable execution plan supported by analytical review, impurity understanding, and practical purification recommendations for advanced intermediates or final API-related outputs.
Electron-poor heterocycles, multiply substituted aryl halides, and nitrogen-rich substrates often create poor turnover and inconsistent conversion in metal-catalyzed coupling reactions. BOC Sciences addresses these issues through targeted ligand-metal pairing, base and solvent engineering, staged reagent addition, and optimization of substrate presentation to improve catalytic efficiency while preserving chemoselectivity.
Sulfur-containing motifs, residual inorganic salts, polar amines, and unstable intermediates can severely reduce catalyst activity. We investigate deactivation pathways, identify interfering components, and redesign the reaction environment to restore turnover, reduce catalyst loading pressure, and build a more reliable and economical catalytic process.
Successful conversion alone is not enough if the product stream carries problematic levels of catalytic residues or metal fines. We connect the reaction step to downstream purification using scavengers, phase management, carbon treatment, crystallization logic, and analytical verification, supported by our heavy metal analysis capabilities.
Hydrogenation and related gas-dependent catalytic steps frequently behave differently outside the laboratory due to gas-liquid mass transfer, catalyst wetting, agitation efficiency, and heat release. Our process chemists develop scale-aware operating strategies that preserve selectivity and batch consistency while improving execution practicality.
From difficult cross-couplings to asymmetric transformations and catalyst cleanup challenges, BOC Sciences delivers practical metal catalysis solutions designed for discovery efficiency and downstream process success.
We focus on catalytic reactions as they behave in real pharmaceutical development settings, balancing conversion, selectivity, raw material practicality, isolation efficiency, and process operability rather than optimizing only for assay yield.
Our team links catalyst screening with broader process R&D needs, ensuring that the catalytic step supports the overall route instead of creating downstream purification, cost, or reproducibility burdens.
We combine reaction development with impurity and residue assessment, helping clients understand catalyst-derived byproducts, incomplete conversion pathways, and cleanup performance using fit-for-purpose analytical strategies.
Whether you need a single catalytic problem solved, a new route for an intermediate, or broader support connected to API synthesis, our services can be adapted to discovery, preclinical, and manufacturing-oriented chemistry programs.
Client Needs: A discovery-stage client required a reliable Pd-catalyzed coupling to connect a chloropyrimidine core with a sterically hindered bicyclic amine for rapid generation of kinase inhibitor analogs. The original literature-like conditions gave low conversion and substantial protodehalogenation.
Challenges: The substrate pair showed poor reactivity, strong base sensitivity, and multiple competing impurity pathways. Scale-up was further complicated by catalyst black formation and inconsistent filtration behavior.
Solution: BOC Sciences performed structured catalyst and ligand screening across palladium sources, biaryl phosphines, inorganic and organic bases, solvent polarity windows, and reagent addition modes. We identified a milder catalytic system with controlled water content and staged amine addition that significantly improved turnover while suppressing side reactions and delivering a more stable, reproducible reaction profile across repeated laboratory batches.
Outcome: The optimized process delivered a robust coupling step suitable for repeated analog preparation, increasing isolated yield, improving crude purity, and simplifying downstream purification for medicinal chemistry throughput.
Client Needs: A small molecule development program required a chiral benzylic amine intermediate produced through asymmetric hydrogenation of a trisubstituted enamide, with high stereocontrol and a process suitable for route advancement.
Challenges: The substrate displayed catalyst sensitivity, partial over-reduction under several common conditions, and variable performance when scaled beyond initial laboratory screening. The project also demanded practical catalyst loading and clean isolation.
Solution: We evaluated multiple Rh- and Ir-based chiral catalyst systems, solvent combinations, substrate concentrations, and hydrogen pressure profiles. Through iterative optimization, our team selected a catalytic package that balanced enantioselectivity, chemoselectivity, and workup simplicity, while redesigning isolation around a stable crystalline salt intermediate and improving batch robustness under extended reaction and hold-time conditions.
Outcome: The final process provided a reproducible asymmetric transformation with strong stereochemical performance and a cleaner impurity profile, enabling the client to move forward with a more practical chiral route.
Client Needs: A process chemistry team developing a heteroaryl API intermediate needed to reduce palladium carryover after a late-stage coupling step that otherwise showed excellent conversion and selectivity.
Challenges: Residual catalyst and metal fines persisted through conventional aqueous workup and standard carbon treatment. Product losses increased when more aggressive cleanup methods were attempted, making the process inefficient and difficult to control.
Solution: BOC Sciences combined reaction quench redesign with scavenger screening, pH-dependent extraction mapping, and crystallization-based purge studies. We also refined filtration strategy and assessed product-metal interactions analytically to identify the most efficient cleanup sequence, while preserving isolation recovery and minimizing added operational complexity during downstream processing.
Outcome: The revised process substantially lowered metal burden while preserving product recovery and improving consistency, giving the client a catalytic route that was cleaner, more scalable, and easier to reproduce.
Metal catalysis technology has become a critical tool in drug development because it enables the efficient construction of complex molecular frameworks, especially for forming key C–C, C–N, and C–O bonds. It can significantly improve the efficiency of hit-to-lead work, route scouting, and synthetic optimization by offering strong selectivity, better step economy, and greater route flexibility. For projects that require rapid structure–activity relationship exploration, metal-catalyzed reactions often help reduce unnecessary transformations and streamline synthesis. As a result, metal catalysis is now a core capability in modern medicinal chemistry and process-oriented small molecule development.
In drug molecule synthesis, the most widely used metal-catalyzed reactions include palladium-catalyzed cross-coupling, copper-catalyzed coupling and amination, nickel-catalyzed cross-coupling, rhodium- or ruthenium-mediated asymmetric catalysis, and a range of transition metal systems used for reduction, hydrogenation, and C–H functionalization. These reactions are broadly applied in biaryl construction, heterocycle modification, chiral center formation, and late-stage functionalization. For drug development clients, the key value lies not only in knowing which reaction class to use, but in selecting the most suitable catalytic platform and condition set based on substrate properties, functional group tolerance, and downstream development goals.
Selecting the right metal catalysis strategy requires a comprehensive evaluation of molecular complexity, substrate electronics and steric effects, functional group compatibility, reaction selectivity, scale-up potential, and the connectivity between upstream and downstream steps. In pharmaceutical development, the best solution is not always the most cited literature condition, but the one that best fits the practical needs of the project. BOC Sciences can support clients with integrated services ranging from catalyst and ligand screening to reaction optimization and custom synthesis, helping project teams identify robust and practical routes more efficiently while reducing repeated effort in later-stage development.
Metal catalysis is especially valuable for solving synthetic challenges such as low reaction efficiency, poor selectivity, lengthy routes, or difficulties in introducing key structural fragments. It is particularly effective in the construction of highly substituted aromatic systems, complex heterocycles, chiral intermediates, and late-stage molecular modifications. For drug development teams seeking to accelerate candidate optimization, these technologies can expand accessible chemical space and improve flexibility in route design. With a well-designed catalytic system, critical transformations can often be achieved in fewer steps, supporting faster analogue generation and broader structural diversification.
The success of a metal catalysis project depends heavily on practical experience rather than reaction type alone. Different substrates may respond very differently to metal sources, ligands, bases, solvents, and reaction windows, and even small changes can strongly affect conversion and selectivity. An experienced service partner can more quickly identify technical risks, narrow down screening parameters, and recommend strategies that better align with pharmaceutical development objectives. As a drug development service provider, BOC Sciences offers strong capabilities in complex organic synthesis, catalytic route development, and customized project support, helping clients translate metal catalysis technologies into practical development outcomes with greater confidence and efficiency.
Our coupling step had stalled for weeks because the substrate combination simply did not behave under standard screening conditions. BOC Sciences approached it like true process chemists, not just reaction testers, and quickly identified a workable catalytic window.
— Dr. James T., Senior Scientist, Small Molecule Discovery
What impressed us most was their ability to connect catalyst selection with the full synthetic route. Their recommendations improved not only conversion, but also workup, metal cleanup, and overall process simplicity.
— Maria L., Director of Process Chemistry
We needed an asymmetric catalytic solution that could move beyond a promising screening result and become a practical synthetic step. The BOC Sciences team delivered strong stereochemical performance together with a realistic isolation strategy.
— Dr. Kevin R., CMC Project Lead
Our product quality issues were tied to post-reaction metal carryover, and several attempted cleanup approaches cost us too much yield. BOC Sciences developed a smarter purification strategy that reduced the burden without complicating the process.
— Helen P., Head of Technical Operations
If you have any questions or encounter issues on this page, please don't hesitate to reach out. Our support team is ready to assist you.
